During the past decade, MHAT Hadzhi Dimitar conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MHAT Hadzhi Dimitar" are "Diabetic Retinopathy" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "MHAT Hadzhi Dimitar" in a lesser frequency.

Most popular intervention types in "MHAT Hadzhi Dimitar" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Finerenone (BAY94-8862)" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Hadzhi Dimitar" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Hadzhi Dimitar". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MHAT Hadzhi Dimitar, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Hadzhi Dimitar, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".